First Xarelto Lawsuit Trial For A State Court Begins In Philadelphia

   

Xarelto Bleeding Lawsuit Filings Allege Patients Suffer Brain Bleeds, Stroke, Internal Bleeding And Death After Taking The Anticoagulant Medication.

xarelto-lawsuit-side-effects-lawyerThe first Xarelto trial for a state court lawsuit over the blood thinner began Monday in the Philadelphia Court of Common Pleas. The allegations in the Xarelto trial mirrors those in thousands of Xarelto bleeding side-effects lawsuits filed nationwide against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals. Xarelto users allege in lawsuits that they suffered brain bleeds, gastrointestinal hemorrhaging, internal bleeding, stroke, and even death after taking Xarelto.

In addition to patients who were prescribed Xarelto, survivors of Xarelto users have also filed lawsuits alleging their loved ones suffered a fatal bleeding episode after taking the blood thinner. Over 1,500 Xarelto complaints are pending in a mass tort in Philadelphia while federal lawsuits over the blood thinner are pending in a multidistrict litigation (MDL) in the Eastern District of Louisiana. The 18,500 federal Xarelto complaints were consolidated for coordinated pretrial proceedings. (In Re: Xarelto Litigation, Case ID 150102349) (In Re: Xarelto Products Liability Litigation, No. 2592)

“Based on allegations in Xarelto lawsuits, patients continue to suffer serious bleeding episodes and other significant complications because of the blood thinner,” says Dr. François Blaudeau, founder of Southern Med Law, who is also an attorney and practicing physician.

Dr. Blaudeau and the firm’s attorneys possess a unique understanding of the medical and legal questions relating to Xarelto lawsuits. If you or a loved one experienced life-threatening internal bleeding or other complications allegedly associated with Xarelto, please contact Southern Med Law as soon as possible to learn more about your legal rights. You can arrange for a free, no obligation Xarelto lawsuit review by calling Southern Med Law today, at 205-547-5525.

The trial currently underway in Philadelphia involves an Indiana woman who suffered an excessive bleeding event after being prescribed Xarelto to treat atrial fibrillation, according to the lawsuit. The complaint alleges that Bayer understated in the warning label that Xarelto could place patients at risk for gastrointestinal bleeds, and other major bleeding events. In opening arguments, the plaintiff’s attorneys accused the defendants of influencing Xarelto’s clinical trials to make it appear that Xarelto was safer and more effective than warfarin, an older blood thinner. (Xarelto Case No. 160503416; In Re: Xarelto Products Liability Litigation, No. 2592)

Xarelto (rivaroxaban) was approved by the U.S. Food & Drug Administration (FDA) in 2011. Xarelto was initially approved to reduce the risk of strokes, deep vein thrombosis, pulmonary embolism, and blood clots in patients who have undergone hip or knee replacement surgery. The blood thinner’s approval was later expanded to include preventing blood clots in patients with atrial fibrillation (irregular heartbeat), as well as treating deep vein thrombosis and pulmonary embolism.

Xarelto lawsuit plaintiffs claim that Bayer and Janssen misled patients by positioning the drug as a superior alternative to warfarin (Coumadin, Jantoven), the oldest FDA blood thinner approved to treat atrial fibrillation. Xarelto, along with Eliquis and Pradaxa, are new generation blood thinners compared to warfarin which the FDA approved in1954. The newer blood thinners are promoted as being more convenient to use because patients do not have to undergo routine blood tests as do patients who take warfarin.

The FDA warns that the Xarelto and Eliquis blood thinners do not have FDA-approved antidotes to reverse any bleeding side effects patients experience. Warfarin, however, uses vitamin K to reverse the anticoagulation effects of warfarin’s bleeding side effects. Praxbind is used to reverse Pradaxa’s anti-clotting effects.
[xarelto-us.com/blood-thinner/xarelto-vs-warfarin]
[fda.gov/Drugs/NewsEvents/ucm405148.htm]

About Southern Med Law And Filing A Xarelto Bleeding Lawsuit
Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective attorney and advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
francois@southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam
www.southenmedlaw.com

This entry was posted in Southern Med Law | Article. Bookmark the permalink.